Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong · Delayed Price · Currency is HKD 4.400
-0.130 (-2.87%)
Jun 18, 2026, 3:35 PM HKT
HKG:1167 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -145.98 | -155.71 | -359.12 | -371.86 | -301.19 |
Depreciation & Amortization | 22.81 | 26.46 | 25.08 | 13.8 | 10.79 |
Loss (Gain) From Sale of Assets | -19.17 | 0.14 | -0.63 | - | - |
Loss (Gain) From Sale of Investments | 0.9 | 0.02 | 7.24 | -4.19 | -0.19 |
Loss (Gain) on Equity Investments | 0.53 | - | - | - | - |
Stock-Based Compensation | 4.48 | 9.96 | 14.86 | 16.99 | 19.45 |
Other Operating Activities | -0.98 | -32.06 | -38.48 | -79.07 | 15.25 |
Change in Accounts Receivable | -1.16 | 1.66 | 5.69 | 79.07 | 89.03 |
Change in Accounts Payable | -72.59 | 36.77 | -15.36 | 45.5 | 22.77 |
Change in Unearned Revenue | -0.41 | -0.42 | -0.42 | -0.42 | -3.24 |
Change in Other Net Operating Assets | 0.53 | 39.06 | -3.07 | 7.75 | -0.16 |
Operating Cash Flow | -211.05 | -74.12 | -364.2 | -292.42 | -147.49 |
Capital Expenditures | -1.1 | -12.09 | -37.83 | -16.44 | -10.11 |
Sale of Property, Plant & Equipment | 986.52 | 0.26 | 1.73 | 0.09 | 0.01 |
Sale (Purchase) of Intangibles | -0.57 | - | -0.83 | -0.06 | -1.03 |
Investment in Securities | -1,127 | 217.47 | -27.71 | -667.47 | 178.76 |
Other Investing Activities | 24.9 | 50.59 | 17.25 | -2.43 | -5.97 |
Investing Cash Flow | -117.42 | 256.22 | -47.39 | -686.32 | 161.67 |
Long-Term Debt Issued | 114.87 | 87.7 | 73.62 | - | - |
Total Debt Issued | 114.87 | 87.7 | 73.62 | - | - |
Long-Term Debt Repaid | -102.19 | -100.28 | -13.5 | -7.6 | -11.37 |
Total Debt Repaid | -102.19 | -100.28 | -13.5 | -7.6 | -11.37 |
Net Debt Issued (Repaid) | 12.68 | -12.58 | 60.12 | -7.6 | -11.37 |
Issuance of Common Stock | 45 | 45 | 199.14 | - | 132.83 |
Repurchase of Common Stock | -11.28 | -4.57 | -5.68 | - | - |
Other Financing Activities | -5 | -6.58 | -7.91 | -2.26 | -12.41 |
Financing Cash Flow | 41.41 | 21.28 | 245.66 | -9.85 | 109.06 |
Foreign Exchange Rate Adjustments | -16.26 | 4.55 | 10.7 | 85.77 | -26.44 |
Net Cash Flow | -303.32 | 207.94 | -155.22 | -902.83 | 96.79 |
Free Cash Flow | -212.15 | -86.21 | -402.03 | -308.86 | -157.6 |
Free Cash Flow Margin | -396.35% | -55.37% | -632.92% | -322.58% | -103.13% |
Free Cash Flow Per Share | -0.27 | -0.11 | -0.52 | -0.41 | -0.21 |
Cash Interest Paid | 5 | 6.58 | 7.91 | 2.26 | 0.51 |
Levered Free Cash Flow | -58.42 | -41.72 | -267.43 | -158.82 | -67.48 |
Unlevered Free Cash Flow | -50.34 | -36.47 | -262.23 | -157.41 | -67.12 |
Change in Working Capital | -73.63 | 77.07 | -13.15 | 131.92 | 108.4 |